Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 22, 1999

View Archived Issues

Company Profile: Wilex

M.D. Anderson Cancer Center and Cryogenic Solutions enter antisense collaboration

Licensing opportunity from NIH: chimeric proteins for preventing, treating HIV infection

AM-36: profile of a novel hybrid neuroprotectant

Dolastatins 1, 2 and 3 available for licensing from ASU

Novel partial estrogen agonists developed at American Home Products

Meiji Seika's new integrin receptor antagonists useful as antiplatelet, antiadhesion agents

Specific inhibitors of eosinophil function from Kaken useful for asthma

New 2-oxoindoles synthesized at Maruho inhibit cytokine production

deCODE Genetics maps gene linked to preeclampsia

European patent covers Lilly's new ampakine-like compounds

Nalmefene reduces relapse to heavy drinking

Incyte reports discovery of new human PKC inhibitor

New class of potent antitumor agents devoid of calcemic activity designed at Roche

Results of SAR in the AAP-BHAP class of NNRTIs published by Pharmacia & Upjohn

InSite expands genetic research program for glaucoma

AHP pays milestone to Ligand for progesterone receptor antagonist

Single-dose pharmacokinetics and toxicity of new anthracycline examined in animals and man

CHF-3316 - a new isoflavone with characteristics of a SERM

Alza stockholders approve merger agreement with Abbott

Combination of anti-TNF product and dexamethasone additive or synergistic in arthritic rats

FDA approves Rhone-Poulenc Rorer's Synercid

Cypros receives fast track status for Cordox in CABG surgery

Oxis Therapeutics announces phase IIa results in UC trial

BMS and Otsuka establish agreement for novel schizophrenia treatment

Effects of NDD-094 on sensorimotor deficits in rat stroke model